| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| rozrolimupab | blood group rh(d) polypeptide | NA | Clinical trial target | TTD , DGIDB | Thrombocytopenia[MeSHID:D013921] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Anemia[MeSHID:D000740] |
21.22 | discontinued in phase 2 | inhibitor |
| rozrolimupab | rhesus blood group d antigen | biotech | NA | drugbank , DGIDB | Thrombocytopenia[MeSHID:D013921] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Anemia[MeSHID:D000740] |
21.22 | investigational | inhibitor |
| click here to return to the previous page | ||||||||